Phosphorylation of the HuR ligand APRIL by casein kinase 2 regulates CD83 expression (Q39897656)

15 September 2017

title

Phosphorylation of the HuR ligand APRIL by casein kinase 2 regulates CD83 expression (English)

1 reference

15 September 2017

0 references

Jan Chemnitz

1

1 reference

15 September 2017

Dorothea Pieper

series ordinal

2

1 reference

15 September 2017

Cordula Grüttner

series ordinal

3

1 reference

15 September 2017

Joachim Hauber

series ordinal

4

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

European Journal of Immunology

15 September 2017

published in

1 reference

15 September 2017

volume

39

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

267-279

1 reference

Dendritic cells and the control of immunity

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Dendritic cells: specialized and regulated antigen processing machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Antigen presentation and T cell stimulation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Enhanced activation of CD83-positive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

The soluble form of CD83 is present at elevated levels in a number of hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Alternative splicing generates putative soluble CD83 proteins that inhibit T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Cutting edge: CD83 regulates the development of cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Role of CD83 in the immunomodulation of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

CD83 on dendritic cells: more than just a marker for maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

CD83: an update on functions and prospects of the maturation marker of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

21 January 2018

Directing mRNA export.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Nuclear export of mRNA: from the site of transcription to the cytoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Stimulated expression of mRNAs in activated T cells depends on a functional CRM1 nuclear export pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Expression of CD83 is regulated by HuR via a novel cis-active coding region RNA element

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

21 January 2018

HuR and mRNA stability

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Protein ligands to HuR modulate its interaction with target mRNAs in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Analysis of nucleocytoplasmic trafficking of the HuR ligand APRIL and its influence on CD83 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

The Anp32 family of proteins containing leucine-rich repeats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Specificity and mechanism of action of some commonly used protein kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2').

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

One-thousand-and-one substrates of protein kinase CK2?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Order or chaos? An evaluation of the regulation of protein kinase CK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

CD83 expression influences CD4+ T cell development in the thymus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Ribonucleoprotein infrastructure regulating the flow of genetic information between the genome and the proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Linking nuclear mRNP assembly and cytoplasmic destiny

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

From birth to death: the complex lives of eukaryotic mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

A systems view of mRNP biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

RNA regulons: coordination of post-transcriptional events

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Transport of messenger RNA from the nucleus to the cytoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

21 January 2018

Nuclear export of RNA.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Protein and RNA export from the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

CRM1-dependent, but not ARE-mediated, nuclear export of IFN-alpha1 mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Mechanisms of Receptor-Mediated Nuclear Import and Nuclear Export

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Targeting CK2 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Protein kinase CK2: a challenge to canons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

A novel casein kinase 2 alpha-subunit regulates membrane protein traffic in the human hepatoma cell line HuH-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Heat-induced relocalization of protein kinase CK2. Implication of CK2 in the context of cellular stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

CK2 inhibits apoptosis and changes its cellular localization following ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Host determinants in HIV infection and disease. Part 1: cellular and humoral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

Transcription factor NF-kappaB regulates inducible CD83 gene expression in activated T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

7 January 2021

CD83 knockdown in monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

7 January 2021

Effect of pentoxifylline on differentiation and maturation of human monocyte-derived dendritic cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

7 January 2021

Overexpression of phosphodiesterases in experimental autoimmune myasthenia gravis: suppression of disease by a phosphodiesterase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

7 January 2021

Relationship of Apolipoprotein E and Age at Onset to Parkinson Disease Neuropathology

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

7 January 2021

The raison d'être of constitutively active protein kinases: the lesson of CK2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

7 January 2021

Eukaryotic mRNPs may represent posttranscriptional operons

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

7 January 2021

Organizing mRNA export

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

7 January 2021

Heat shock mediated modulation of protein kinase CK2 in the nuclear matrix

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

7 January 2021

Transcription-Dependent and Transcription-Independent Nuclear Transport of hnRNP Proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838619

7 January 2021

Identifiers

DOI

10.1002/EJI.200838619

1 reference

15 September 2017

1 reference